SCHEMBL7209036

SCHEMBL7209036

COC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)N1CCC(Cc2ccccc2)CC1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.69
KMT2A Q03164 4/20 0.69
POLB P06746 4/20 0.62
GAA P10253 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.53
PSMB11 A5LHX3 2/20 0.52
PSMA7 O14818 2/20 0.52
PSMB1 P20618 2/20 0.52
PSMA1 P25786 2/20 0.52
PSMA2 P25787 2/20 0.52
PSMA3 P25788 2/20 0.52
PSMA4 P25789 2/20 0.52
PSMB8 P28062 2/20 0.52
PSMB9 P28065 2/20 0.52
PSMA5 P28066 2/20 0.52
PSMB4 P28070 2/20 0.52
PSMB6 P28072 2/20 0.52
PSMB5 P28074 2/20 0.52
PSMB10 P40306 2/20 0.52
PSMB3 P49720 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7208720 0.97 MEN1 (0.72) MEN1KMT2APOLBGAASMN1; SMN2
SCHEMBL4729475 0.90 POLB (0.71) MEN1KMT2APOLBGAAPSMB11
SCHEMBL4725802 0.84 POLB (0.61) MEN1KMT2APOLBPSMB11PSMA7
SCHEMBL7345585 0.79 CACNA1B (0.68) POLBPSMB11PSMA7PSMB1PSMA1
SCHEMBL7343475 0.76 IL1RN (0.62) POLBGAAPSMB11PSMA7PSMB1
SCHEMBL7343480 0.76 IL1RN (0.62) POLBGAAPSMB11PSMA7PSMB1
SCHEMBL18396386 0.76 PSMB5 (0.62) KMT2APOLBGAAPSMB11PSMA7
SCHEMBL3598801 0.74 SLC6A2 (0.49) MEN1KMT2A
SCHEMBL4575868 0.74 CTSK (0.75) CTSS
SCHEMBL7163409 0.74 CTSK (0.75) CTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6617426-B1 Peptide analogs of given formula; useful in treating neurodegenerative, autoimmune, cognitive disorders, stroke and traumatic injury MERCK SHARP & DOHME CORP. 2003-09-09 US disclosed
EP-1194443-A1 CYSTEINYL PROTEASE INHIBITORS Merck & Co., Inc. (US) 2002-04-10 EP disclosed
WO-2000078794-A1 CYSTEINYL PROTEASE INHIBITORS MERCK & CO., INC. (US) 2000-12-28 WO disclosed